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Abstract 
This study provides an information about the mechanisms of liver injury induced 
by CCl4, and determines the influence of administration of L-carnitine or/and 
CoQ10 as prophylactic agents against CCl4 deteriorative effect. The study was 
carried out on 80 adult male albino rats divided into eight groups, 10 animals 
each, as follows: four normal groups (control, treated with L-carnitine, treated 
with CoQ10, and treated with a combination of Lcarnitine and CoQ10) and four 
liver injury groups treated with CCl4 (control, treated with L-carnitine, treated 
with CoQ10, and treated with a combination of L-carnitine and CoQ10). Liver 
injury was induced by s.c. injection of a single dose of CCl4 (1  ml/kg). 
L-carnitine (50 mg/kg/day) was given i.p. for four successive days 24 hours 
before CCl4 injection, and CoQ10 (200 mg/kg) was given as a single i.p. dose 
24 hours before CCl4 injection. Animals were sacrificed 24 hours after CCl4 
injection, blood samples were withdrawn and liver tissue samples were 
homogenized. The levels of the following parameters were determined: hepatic 
reduced glutathione, serum ALT and AST, hepatic lipid peroxides, hepatic 
vitamin C, hepatic and serum total protein, serum albumin, serum sialic acid, 
serum nitrite, and serum and hepatic total LDH activities and LDH isoenzymes. 
The obtained data revealed that CCl4 injection produced a significant decrease 
in reduced glutathione content, vitamin C, total protein and albumin levels. 
However, there was a significant increase in serum ALT and AST activities, lipid 
peroxides, sialic acid, nitric oxide, serum and hepatic total LDH activities. On 882  S. A. Ali et al.:  
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the other hand, groups treated with L-carnitine or/and CoQ10 prior to CCl4 
injection showed an improvement in most parameters when compared with 
cirrhotic control group. It has been concluded that L-carnitine and coenzyme 
Q10 have a pronounced prophylactic effect against liver damage induced by 
halogenated alkanes such as carbon tetrachloride. 
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Introduction 
The use of many halogenated alkanes such as carbon tetrachloride (CCl4), chloroform 
(CHCl3), or iodoform (CHI3) has been banned or severely restricted because of their 
distinct toxicity. Yet CCl4 continues to provide an important service today as a model 
substance to elucidate the mechanisms of action of hepatotoxic effects such as fatty 
degeneration, fibrosis, hepatocellular death and carcinogenicity [1, 2]. 
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Fig. 1.  Structure of L-Carnitine 
L-carnitine is 4-trimethylamino-3-hydroxybutyrate (Fig.  1). It is an amino acid derivative 
that is found in nearly all cells of the body and occurs naturally in animal products. It is 
synthesized chiefly in the liver and kidneys from the essential amino acid L-lysine [3]. Liver 
is one of the main sources of endogenous carnitine synthesis from lysine, methionine, 
ascorbate, niacin, pyridoxine and Fe
2+. Carnitine is captured and stored by muscle 
because there is no carnitine synthesis in muscle [4]. Carnitine deficiencies may cause 
symptoms such as fatigue, chest pain, muscle pain, weakness, low blood pressure, and/or 
confusion. A healthcare provider may recommend use of the supplement levocarnitine 
(L-carnitine) for individuals who have a suspected or confirmed deficiency of this nutrient.  
Coenzyme Q10 (CoQ10) or ubiquinone is a vitamin-like substance which is found in small 
amounts in a wide variety of foods and is synthesized in all tissues. CoQ10 is the 
coenzyme for at least three mitochondrial enzymes (complexes I, II and III). Mitochondrial 
enzymes of the oxidative phosphorylation pathway are essential for the production of the 
high-energy phosphate containing compound, adenosine triphosphate (ATP), upon which 
all cellular functions depend [5]. Coenzyme Q besides its bioenergetic function in 
mitochondrial respiratory chain is a powerful lipid-soluble antioxidant synthesized in the 
liver [6]. Protective effects of vitamin E and coenzyme Q administration found in 
experimental models of CCl4-induced cell necrosis support the role of free radicals in liver 
damage [7]. The structures of CoQ10 and its redox transitions are shown in Fig. 2.   Protective Effect of L-Carnitine and Coenzyme Q10 on CCl4-Induced Liver Injury in Rats  883 
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Fig. 2.  The Redox Transitions of CoQ10  
The aim of this work is to evaluate the prophylactic effect of L-carnitine, coenzyme Q10 
(CoQ10) or their combination against the deteriorative effect induced by carbon 
tetrachloride (CCl4) on serum & liver. Administration of CCl4 provides a suitable animal 
model for free radical damage in liver such as fatty degeneration, fibrosis and 
hepatocellular death. 
Results 
CCl4 injection produced a significant decrease in hepatic reduced glutathione (GSH); 
Ascorbic Acid (Vit C); total protein content as compared to normal control value. 
Administration of L-carnitine or/and coenzyme Q10, significantly increased these 
parameters compared to CCl4 control group as shown in Tables 1, 2. The percentages of 
improvement were 28.79%, 27.11% and 29.51%;(GSH) 16.42%, 27.55% and 29.91% (Vit 
C); 16.3%, 22.59% and 28.6% (total protein) on injection of L-carnitine, coenzyme Q10 and 
their combination respectively. Thus, combination has achieved the most liver protection. 
Also, CCl4 cause a significant decrease in serum total protein level; serum albumin 
compared to normal control value. Administration of L-carnitine or/and coenzyme Q10 (prior 
to CCl4 injection) significantly increased serum total protein and albumin levels as 
compared to CCl4 control group as shown in Table 1. The percentages of improvement 
were 44.43%, 65.29% and 67.53% (serum total protein) 14.17%, 10.9% and 21.65% 
(albumin) on injection of L-carnitine, coenzyme Q10 and their combination respectively. 
Thus, combination has achieved the most liver protection. 
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Tab. 1.  Levels of ALT, AST, albumin, Nitrate, Sialic acid, total protein and LDH activity 
in the serum of different groups. 
Normal Groups  CCL4-Injury groups 
Parameter  Contr. 
(I) 
L-Carn. 
(II) 
CoQ10 
(III) 
L-Carn. +
CoQ10 
(IV) 
Contr. 
(V) 
L-Carn. 
(VI) 
CoQ10 
(VII) 
L-Carn. +
CoQ10 
(VIII) 
ALT 
(U/ml) 
29.32 ± 
2.57 
27.18 ± 
3.22 
16.397* ±
4.82 
26.38 ± 
3.91 
37.49* ± 
4.68 
29.59
# ± 
0.69 
21.03
# ± 
1.87 
21.05
# ± 
1.16 
AST 
(U/ml) 
71.19 ± 
5.16 
62.38* ± 
3.07 
56.45* ± 
3.43 
59.85* ± 
5.40 
109.82* ±
7.86 
90.82
# ± 
7.65 
87.66
# ± 
6.06 
84.09
# ± 
3.37 
Albumin 
(gm/dl) 
6.17 ± 
0.118 
6.11 ± 
0.19 
6.17 ± 
0.1338 
5.89 ± 
0.21 
4.72* ± 
0.32 
5.59
# ± 
0.22 
5.39
# ± 
0.37 
6.06
# ± 
0.20 
Nitrite 
(µmol/L) 
16.01 ± 
1.11 
7.40* ± 
1.64 
13.38 ± 
2.635 
16.64 ± 
1.36 
26.79* ± 
1.04 
22.53
# ± 
2.69 
24.07 ± 
2.58 
18.45
# ± 
2.00 
Sialic Acid 
(mg/dl) 
54.55 ± 
4.59 
36.86* ± 
7.02 
45.69 ± 
9.383 
44.71 ± 
9.19 
94.59* ± 
9.59 
58.49
# ± 
10.97 
52.28
# ± 
7.50 
51.6
# ± 
6.45 
Total Protein 
(mg/ml) 
19.3 ± 
0.42 
17.32 ± 
1.26 
20.8 ± 
0.91 
20.8 ± 
0.59 
5.5* ± 
0.14 
14.07
# ± 
1.33 
18.1
# ± 
0.26 
18.53
# ± 
2.00 
LDH 
(µmol/mg 
protein/min) 
81.42 ± 
13.47 
77* ± 
11.76 
49.15* ± 
14.8 
91.14* ± 
11.04 
209.6* ± 
3.94 
164.8
# ± 
10.69 
150.7
# ± 
1.25 
128.3
# ± 
2.04 
Data are expressed as mean ± SD of ten rats in each group. Treated normal groups are compared with 
normal control group CCL4-Injury group is compared with normal control group. Treated CCL4 groups are 
compared with cirrhotic control group. Difference between groups is analyzed by one-way ANOVA, where: 
*…significantly different from group I at P < 0.05; 
#…significantly different from group V at P < 0.05. 
 
While, showed a significant increase in serum ALT& AST activities as compared to normal 
control value. After treatment, significantly decreased in the two enzymes activities 
compared to CCl4 control group as shown in Table 1 the percentages of improvement 
were 26.94%, 56.12% and 56.7 % (ALT) 26.69%, 31.13% and 36.15 % (AST) on injection 
of L-carnitine, coenzyme Q10 and their combination respectively. Thus, combination has 
achieved the most liver protection. Also, CCl4 showed a significant increase in serum sialic 
acid; nitrite levels; total LDH activity and hepatic malondialdehyde (LPO) level compared to 
normal control value. Administration of any one of the three compounds prior to CCl4 
injection) significantly decreased in all mentioned parameters compared to CCl4 control 
group as shown in Table 2.  
The percentages of improvement were 66.18%, 77.57% and 78.81% sialic acid, 26.6%, 
16.98% and 52.08% (nitrite level) 55.02%, 72.34% and 99.85% total LDH activity and 
86.25%, 97.55% and 94.63% hepatic malondialdehyde level injection of L-carnitine, 
coenzyme Q10 and their combination respectively. Thus, Coenzyme Q10 is more effective 
than L-carnitine in most parameters as AST, Sialic Acid, serum & hepatic total protein, 
serum &hepatic LDH,lipid peroxide and vitamin C and the best effects of the combination 
has achieved the most liver protection as shown in tables 1 and 2. 
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Tab. 2.  Levels of GSH, Lipid peroxide, Vit. C, total protein, LDH activity in the liver of 
different groups. 
Normal Groups  CCL4-Injury groups 
Parameter  Contr. 
(I) 
L-Carn. 
(II) 
CoQ10 
(III) 
L-Carn. +
CoQ10 
(IV) 
Contr. 
(V) 
L-Carn. 
(VI) 
CoQ10 
(VII) 
L-Carn. +
CoQ10 
(VIII) 
GSH 
(mg/gm tissue) 
3.93 ± 
0.07 
5.33* ± 
0.88 
6.186* ±
.92 
5.811* ± 
1.00 
2.507* ± 
0.40 
3.638
# ± 
0.19 
3.572
# ± 
0.85 
3.67
# ± 
0.41 
Lipid peroxide 
(nmol/mg 
protein) 
2.568 ± 
0.12 
2.251* ± 
0.18 
2.339 ± 
0.32 
1.683* ± 
0.26 
5.985* ± 
0.27 
3.77
# ± 
0.12 
3.48
# ± 
0.16 
3.555
# ± 
0.11 
Vit C (ascorbic 
acid) 
(µg/gm tissue) 
101.08 ±
8.06 
99.47 ± 
6.61 
90.81 ± 
9.34 
93.185 ± 
11.28 
51.26* ± 
6.09 
67.86
# ± 
5.52 
79.112
# ± 
1.29 
81.49
# ± 
8.73 
Total Protein 
(mg/gm tissue) 
250.11 ±
23.58 
258.28 ± 
35.71 
256.05 ±
8.83 
287.96* ±
35.4 
176.48* ±
6.23 
217.24
# ± 
14.96 
232.99
# ± 
20.36 
248
# ± 
19.06 
LDH 
(µmol/mg 
protein/min) 
114 ± 
1.06 
88.9* ± 
0.15 
99.57* ±
4.43 
97.6* ± 
1.05 
181.9* ± 
1.71 
163.9
# ± 
5.73 
155.3
# ± 
1.46 
134.9
# ± 
5.48 
Data are expressed as Mean ± SD of ten rats in each group. Difference between groups is analyzed by one-
way ANOVA, where: *…significantly different from group I at P < 0.05; 
#…significantly different from group V 
at P < 0.05. 
 
Separation of LDH Isoenzymes by Gel Electrophoresis 
Hepatic Total Lactate Dehydrogenase (LDH) Activity 
CCl4 injection produced a significant increase in hepatic total LDH activity at P < 0.05 
compared to normal control value. Administration of L-carnitine or/and coenzyme Q10 (prior 
to CCl4 injection) significantly decreased hepatic total LDH activity compared to CCl4 
control group as shown in Table 3. The percentages of improvement were 15.79%, 
23.33% and 41.23% on injection of L-carnitine, coenzyme Q10 and their combination 
respectively. Thus, combination has achieved the most liver protection. 
Tab. 3.  Total activity of hepatic LDH Isoenzymes.  
Normal Groups  CCL4-Injury groups  LDH 
Isoenzymes 
(µmol/mg 
protein/min) 
Contr.
(I) 
L-Carn. 
(II) 
CoQ10
(III) 
L-Carn. +
CoQ10 
(IV) 
Contr. 
(V) 
L-Carn.
(VI) 
CoQ10 
(VII) 
L-Carn. + 
CoQ10 
(VIII) 
LDH-1 –  –  –  –  –  –  –  – 
LDH-2 1.01  1.298*  1.47*  1.11*  1.32*  1.72
# 2.05
# 1.43
# 
LDH-3 1.85  1.242*  2.99*  3.89*  2.09*  3.74
# 2.85
# 2.44
# 
LDH-4 2.60  2.6  9.84*  9.74*  2.29*  16.88
# 15.22
# 23.29
# 
LDH-5 108.54 83.76*  85.27* 82.89*  176.20* 141.57
# 135.19
# 107.74
# 
Data are expressed as Values are expressed in Mean ± SD of ten rats in each group. Difference 
between groups is analyzed By one-way ANOVA, where: *…significantly different from group I at  
P < 0.05; 
#…significantly different from group V at P < 0.05.  
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Fig. 3A. shows the electrophoretic separation pattern of hepatic lactate dehydrogenase 
isoenzymes in normal and CCL4 groups. It can be observed that hepatic LDH-1 was 
absent in all groups. CCl4 injection resulted in a significant increase in hepatic levels of 
LDH-2, LDH-3 and LDH-5; however, it significantly decreased hepatic LDH-4. The 
administration of any one of the three compounds amelioration all the levels of hepatic 
LDH Isoenzymes, compared to CCl4 group. 
A (Liver)  B (Serum) 
Lanes 1, 2  Normal Control Group  
Lane 3   L-Carnitine Group 
Lane 4   CoQ10 Group 
Lane 5   L-Carnitine & CoQ10 Group 
Lanes 6, 8  CCl4 Group 
Lane 7   Heart (Standard Group) 
Lane 9   L-Carnitine & CCl4 Group 
Lane 10  CoQ10 & CCl4 Group 
Lanes 11, 12  L-Carnitine, CoQ10 & CCl4 Group 
Lanes 1  Normal Control Group  
Lane 2, 3  L-Carnitine Group 
Lane 4   CoQ10 Group 
Lane 5   Heart (Standard Group) 
Lanes 6  L-Carnitine & CoQ10 Group 
Lane 7   CCl4 Group 
Lane 8   L-Carnitine & CCl4 Group  
Lane 9, 10  CoQ10 & CCl4 Group 
Lane 11  L-Carnitine, CoQ10 & CCl4 Group  
Fig. 3.  Electrophoretic Profile of Lactate Dehydrogenase Isoenzymes (LDH-
Isoenzymes) of Male Rats (Liver & Serum). 
Table 4 & Fig. 3B show the electrophoretic separation pattern of serum lactate 
dehydrogenase isoenzymes in normal and cirrhotic groups. It can be observed that CCl4 
injection resulted in a significant increase in serum levels of all LDH isoenzymes. 
Administration of L-carnitine alone significantly decreased serum LDH-1 and LDH-5; 
however, it increased serum LDH-2, LDH-3 and LDH-4 compared to CCl4 control group. 
Administration of coenzyme Q10 alone significantly decreased serum levels of all LDH 
isoenzymes compared to CCl4  control group. On the other hand, administration of a 
combination of L-carnitine and coenzyme Q10 significantly decreased serum LDH-1, LDH-
2, LDH-3 and LDH-5; however, it increased serum LDH-4 compared to CCl4 control group. 
Tab. 4.  Total activity of serum LDH Isoenzymes.  
Normal Groups  CCL4-Injury groups  LDH 
Isoenzymes 
(µmol/mg 
protein/min) 
Contr.
(I) 
L-Carn. 
(II) 
CoQ10
(III) 
L-Carn. +
CoQ10 
(IV) 
Contr. 
(V) 
L-Carn.
(VI) 
CoQ10 
(VII) 
L-Carn. + 
CoQ10 
(VIII) 
LDH-1 1.33  1.74*  0.83*  3.14*  6.55*  3.47
# 3.86
# 3.05
# 
LDH-2 1.71  1.62*  1.16*  3.72*  7.61*  8.86
# 4.49
# 3.98
# 
LDH-3 3.38  4.43*  1.21*  3.66*  4.89*  8.88
# 3.83
# 3.39
# 
LDH-4 4.25  6.64*  3.07*  5.59*  5.48*  9.27
# 5.35
# 5.10
# 
LDH-5 70.74  62.58*  42.88* 75.02*  185.06* 134.33
# 133.16
# 111.88
# 
Data are expressed as Values are expressed in Mean ± SD of ten rats in each group. Difference 
between groups is analyzed By one-way ANOVA, where: *…significantly different from group I at  
P < 0.05; 
#…significantly different from group V at P < 0.05.    Protective Effect of L-Carnitine and Coenzyme Q10 on CCl4-Induced Liver Injury in Rats  887 
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Discussion 
Carbon tetrachloride is widely used as an animal model of liver damage which is caused 
by formation of trichloromethyl and trichloromethylperoxyl radicals, initiating lipid 
peroxidation and resulting in fibrosis and cell necrosis [8]. Kodai et al. [9] reported that 
there is an increased serum level of MDA in CCl4-induced acute hepatic damage. The 
formation of malondialdehyde was significantly decreased in antioxidant-treated groups 
compared to CCl4-treated group. CCl4 administration induced lipid peroxidation 
accompanied by increases in the plasma malondialdehyde [2,  10]. In this study, CCl4 
injection produced a significant increase in liver LPO level (expressed in terms of 
malondialdehyde). L-carnitine or/and coenzyme Q10 (prior to CCl 4 injection) significantly 
decreased hepatic LPO level. Citil et al. [11] suggested that L-carnitine brought about the 
inhibition of lipid peroxidation by enhancing antioxidant capacity.  
Frei et al. [12] showed that ascorbic acid was effective in inhibiting lipid peroxidation by 
efficiently trapping peroxyl radicals before they can initiate lipid peroxidation. It can also 
protect biological membranes against peroxidative damage, either directly or via 
enhancing the activity of α-tocopherol by maintaining it in its reduced active form. Niki et al. 
[13] have observed a decreased plasma level of vitamin C in cirrhosis stage. CCl4 injection 
produced a significant decrease in hepatic vit C content. Administration of the two 
compounds (prior to CCl4 injection) significantly increased hepatic vit C content, the most 
improvement has been achieved by the combination.  
A significant decrease in the level of hepatic reduced glutathione content in CCl4 
intoxicated rat, these results are in line with the previous studies of Wills and Asha [10] 
have reported a significant reduction in hepatic glutathione content in CCl4-induced hepatic 
damage in rats. Decreased concentration of GSH level could also be a result of 
depression of ATP synthesis and acidosis due to anaerobic glycolysis, Over 90% of GSH 
inflow in systemic circulation is accounted for by the influx of this peptide from the liver 
[14]. This study is in accordance with the above mentioned results and shows that CCl4 
injection produced a significant decrease in hepatic glutathione content, L-carnitine and 
coenzyme Q10 significantly increased hepatic glutathione content  
Our study, liver function tests performed for CCl4 intoxicated rats showed an increase in 
the activities of ALT and AST enzymes. These results are supported by Allis et al. [15]. It is 
observed that administration of L-carnitine or/and coenzyme Q10 significantly decreased 
serum ALT and AST activities. Also, Sumimoto et al. [16] have reported that ischemically 
damaged livers pretreated with CoQ10 showed a decrease in the activity of serum ALT and 
AST.  
CCl4 injection produced a significant decrease in hepatic total protein, this result was 
previously reported by Allis et al. [15]. L-carnitine and coenzyme Q10 treatment significantly 
increased hepatic total protein compared to CCl4 treated group. In accordance with these 
findings, Sumimoto et al. [16] found that ischemically damaged liver that was pretreated 
with CoQ10 showed an increase in levels of total protein to the normal range. As most 
blood proteins are synthesized in the liver, decreased levels can be found in liver injury 
because of decreased liver synthesis. Naik and Panda [17] have observed a decreased 
serum level of total protein in CCl4 induced hepatotoxicity in rats. This level was elevated 
by giving antioxidants prior to CCl4 administration. Also, Wang et al. [18] have reported 888  S. A. Ali et al.:  
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that there is a decreased serum level of total protein in CCl4-induced acute hepatic 
damage. The treatments with antioxidants elevated total protein levels significantly. In this 
work, CCl4 injection produced a significant decrease in serum total protein level 
Administration of either the two compounds significantly increased serum total protein level 
compared to CCl4 group. The liver produces all of the proteins except for the proteins 
synthesized by the immune system (called gamma globulin or immunoglobulin), it does 
this by reassembling amino acids into protein. The main protein produced by the liver is 
albumin [19]. 
Normal albumin in the bloodstream is important for many physiologic functions; one of 
these functions involves the normal maintenance of fluid pressure in the arteries and 
veins. When the protein level falls below a certain point, the fluid in these vessels can leak 
out and pool in the abdominal or thoracic cavities "ascites". Determining serum albumin 
level is often considered as a test for liver function. This is mainly because hepatic 
synthesis of albumin tends to decrease in end-stage liver disease [20]. In this study, CCl4 
caused significant decrease in serum albumin level, Administration of the two compounds 
or their mixture significantly increased serum albumin level. 
Variation in serum sialic acid level in a variety of inflammatory liver diseases is an 
important diagnostic and prognostic tool  [21]. In liver destruction, its level rises 
proportionally to hepatic damage because much of the circulating sialic acid is covalently 
attached to glycoproteins and more than 50% of total sialic acid comes from acute phase 
proteins such as alpha acid glycoproteins, alpha anti-trypsin and fibrinogen, factor VII 
antigen and activation markers of coagulation [22]. 
Several mediators of systemic vasodilatation in liver cirrhosis have been reported. Among 
these is nitric oxide (NO), which has been proposed as one of the main mediators. Tiptoe 
et al. [23] proposed that a high level of nitric oxide is associated with CCl4-induced acute 
liver injury, the study of Nasser et al. [24] showed that serum nitrite levels in cirrhotic 
patients were significantly (P < 0.05) increased in comparison with the controls. In this 
study, the administration of coenzyme Q10 alone did not lead to a significant decrease in 
serum nitrite level compared to CCl4 control group. The most improvement has been 
achieved by the combination.  
Lactate dehydrogenase, in anaerobic glycolysis, catalyzes the conversion of pyruvate to 
lactate which subsequently is converted to glucose in gluconeogenic flux. LDH system 
reflects the NAD
+/NADH ratio indicated by the lactate/pyruvate ratio of hepatocyte cytosol 
[25]. The results obtained in this study showed that CCl4 injection produced a significant 
increase in serum total LDH activity. These elevations are reduced by L-carnitine or/and 
coenzyme Q10.  
Our data are in harmony with Wills and Asha [10] who reported that CCl4 administration in 
rats caused elevation of serum LDH activity. Koudelova et al. [26] have observed that 
pretreatment of intoxicated rats with L-carnitine decreased serum LDH activity probably 
due to membrane stabilizing role of L-carnitine which leads to reduction of LDH leakage 
from liver.  Takeuchi et al. [27] also found that L-carnitine administration significantly 
reduces LDH leakage from intoxicated primary cultured rat hepatocytes. Takayama et al. 
[28] have observed that coenzyme Q10 lowers the increased level of serum LDH in rats 
subjected to hepatic ischemia-reperfusion   Protective Effect of L-Carnitine and Coenzyme Q10 on CCl4-Induced Liver Injury in Rats  889 
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The electrophoretic separation pattern of serum lactate dehydrogenase isoenzymes in 
normal and injury groups showed that CCl4 injection resulted in a significant increase in all 
serum levels of LDH isoenzymes. It was noticed that CCl4 group showed an abnormal 
serum LDH isoenzyme pattern, with a significant increase in all isoenzymes. L-carnitine 
(prior to CCl4 injection) resulted in a significant increase in isoenzyme 2, isoenzyme 3 and 
isoenzyme 4; and a significant decrease in isoenzyme 1 and isoenzyme 5. Treatment with 
coenzyme Q10 (prior to CCl4 injection) resulted in a significant decrease in all isoenzymes. 
Treatment with a combination of L-carnitine and coenzyme Q10 (prior to CCl4 injection) 
resulted in a significant increase in isoenzyme 4 and a significant decrease in 
isoenzyme  1, isoenzyme 2, isoenzyme 3 and isoenzyme 5. Henry and Ferguson [29] 
reported that LDH-1 isoenzyme is maximally active at low concentration of pyruvate and 
inhibited by excess pyruvate, while LDH-5 isoenzyme maintains its activity at high 
pyruvate concentration. In cases of acute viral hepatitis, hepatic LDH concentration is 
altered in about 50% of the patients, with values typically only slightly above the reference 
limit [30]. 
In the present investigation, CCl4 injection produced a significant increase in hepatic LDH 
activity. Administration of L-carnitine or/and coenzyme Q10 significantly decreased hepatic 
total LDH activity compared to CCl4 group. The most improvement has been achieved by 
the combination. Mitcheva et al. [31] reported that CCl4 injection leads to a significant 
increase in LDH leakage from rat hepatocytes. This may be attributed to CCl4-induced 
dehalogenation in the liver endoplasmic reticulum. This process leads to trichlormethyl 
radical (CCl3
•) formation and initiation of lipid peroxidation.  
The electrophoretic separation pattern of hepatic lactate dehydrogenase isoenzymes in 
normal and injury groups showed a disturbance in level of hepatic LDH isoenzymes after 
CCl4 injection. It was noticed that CCl4 group showed an abnormal hepatic LDH isoenzyme 
pattern, with absence of LDH-1, increase in LDH-2, LDH-3, LDH-5 and decrease in LDH-4 
level. Treatment with L-carnitine (prior to CCl4 injection) resulted in a significant increase in 
isoenzyme 2, isoenzyme 3 and isoenzyme 4, a significant decrease in isoenzyme 5, 
whereas isoenzyme 1 was still absent. Treatment with coenzyme Q10 (prior to CCl4 
injection) resulted in a significant increase in isoenzyme 2, isoenzyme 3 and isoenzyme 4, 
a significant decrease in isoenzyme 5, whereas isoenzyme 1 was still absent. Treatment 
with a combination of L-carnitine and coenzyme Q10 (prior to CCl4 injection) resulted in a 
significant increase in isoenzyme 2, isoenzyme 3 and isoenzyme 4, a significant decrease 
in isoenzyme 5, whereas isoenzyme 1 was still absent. 
Materials and Methods 
Animals 
This study was performed on 80 adult male albino rats. The rats were provided by the 
animal house unit of El-Nasr Pharmaceutical Company, Cairo, Egypt. Their weight ranged 
from 150–200 gm (~ 4 months) at the time of experimentation. The animals were housed 
in an animal house unit, in the Biochemistry Department, Faculty of Medicine, El-Minia 
University, in individual metabolic cages and allowed free access to standard diet and 
water. The standard diet was supplied by El-Nasr Pharmaceutical Company. It is 
composed of 72.2% carbohydrates, 3.4% fats, 19.8% proteins, 3.6% cellulose, 0.5% 890  S. A. Ali et al.:  
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vitamins and minerals and 0.5% salts. The rats were left for two weeks for acclimatization. 
All rats were allowed to fast overnight the day before injection. 
Chemicals 
The chemical and solvents used were analar quality, product of Merck, Sigma and El-
Naser Pharmaceutical Chemical Company, Egypt.  
Study Design 
The 80 rats were divided into eight groups, 10 animals each, as follows: 
Group I: Normal control group.  
Group II: Normal group treated with L-carnitine. 
Group III: Normal group treated with CoQ10.  
Group IV: Normal group treated with L-carnitine and CoQ10.  
Group V: CCl4 group.  
Group VI: CCl4 group treated with L-carnitine.  
Group VII: CCl4 group treated with CoQ10. 
Group VIII: CCl4 group treated with L-carnitine and CoQ10. 
Liver fibrosis was induced by subcutaneous (s.c.) injection of a single dose of CCl4 
(1 ml/kg) [32]. L-carnitine (50 mg/kg/day) was given i.p. for four successive days 24 hours 
before CCl4 injection [33], and CoQ10 (200 mg/kg) was given as a single i.p. dose 24 hours 
before CCl4 injection [34]. Animals were sacrificed 24 hours after CCl4 injection, blood 
samples were withdrawn and liver tissue samples were homogenized and stored at -80 
○C. 
Anesthetic procedures complied with the legal ethical guidelines approved by the Ethical 
Committee of the Federal Legislation and National Institutes of Health Guidelines in USA 
were approved by the ethical committee of the National Research Centre in Egypt. 
Samples were subjected to the following biochemical analyses: 
Determination of hepatic reduced glutathione content; serum alanine aminotransferase 
activity; serum aspartate aminotransferase activity. Hepatic lipid peroxides level; hepatic 
ascorbic acid content; serum and hepatic total protein levels; serum albumin level; serum 
sialic acid level; serum nitrite level; serum and hepatic total LDH activities; Separation of 
serum and hepatic LDH isoenzymes by gel electrophoresis.  
Preparation of Serum 
Each rat was anesthetized with diethyl ether, and then the sublingual vein was cut with fine 
scissors. The blood was collected by allowing it to drip into a clean centrifuge tube and 
allowed to clot at room temperature. The serum was separated from the clot by 
centrifugation at 3000 rpm for ten minutes, and then the non-hemolyzed serum was 
transferred into a clean tube and stored at -80 
○C. 
Preparation of Liver Homogenate 
The rat liver was removed, blotted with filter paper and weighed. The liver was 
homogenized under ice after addition of phosphate-buffered saline using Potter-Elvehjem 
homogenizer with Teflon pestle to prepare liver homogenate 20% in phosphate-buffered   Protective Effect of L-Carnitine and Coenzyme Q10 on CCl4-Induced Liver Injury in Rats  891 
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saline. Also, liver homogenate 5% in saline solution and liver homogenate 5% in tris-
glycine buffer were prepared. The homogenates were stored at -80 
○C. 
Determination of Hepatic Reduced Glutathione Content 
Hepatic reduced glutathione was estimated according to the method of Moron et al. [35]. 
Determination of Serum Alanine Aminotransferase Activity 
Serum ALT was determined according to the method of Reitman and Frankel [36].  
Determination of Serum Aspartate Aminotransferase Activity 
Serum AST was determined according to the method of Reitman and Frankel [36].  
Determination of Hepatic Lipid Peroxides Level 
Hepatic lipid peroxides (expressed as malondialdehyde) were estimated by thiobarbituric 
acid as described by Ohkawa et al. [37]. 
Determination of Hepatic Ascorbic Acid Content 
The method adopted by Jagota and Dani [38] was used for estimation of vitamin C. 
Determination of Serum and Hepatic Total Protein Levels 
Serum total protein was estimated according to the method of Bradford [39]. 
Determination of Serum Albumin Level 
Albumin was estimated according to the method of Doumas et al. [40]  
Determination of Serum Sialic Acid Level 
Serum sialic acid was determined using Ehrlich’s reagent, according to the method of and 
Waters et al. [41].  
Determination of Serum Nitrite Level 
Nitrite, a stable end product of nitric oxide radical, is mostly used as an indicator for the 
production of nitric oxide. Serum nitrite was determined by using Griess reagent, according 
to the method of Moshage et al. [42]. 
Determination of Serum and Hepatic Total Lactate Dehydrogenase Activities 
LDH enzyme activity was estimated by the method of Babson and Babson [43] 
Lactate dehydrogenase catalyzes the oxidation of lactate to pyruvate, with concomitant 
reduction of NAD
+.  
Separation of Serum and Hepatic Lactate Dehydrogenase Isoenzymes by Gel 
Electrophoresis 
The method of Dietz and Lubrano [44] was adopted for the preparation of ultra-thin layer of 
5.5% Polyacrylamide gel for separation of LDH isoenzymes. 892  S. A. Ali et al.:  
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Drying 
The gel was taken out and placed up on a piece of cellophane sheets soaked in destaining 
solution and dried on a filter paper. The dry gel can be handled like a piece of paper using 
a glass plate, blinder and clips [45]. 
Scanning: For the evaluation, the dry gel was scanned at 575 nm with Ultrascan Laser 
Densitometer. 
Statistical analyses 
All statistical analyses, including the calculations of mean ± S.D., and statistically analyzed 
using one way analysis of variance (ANOVA) accompanied with post-hoc Significance was 
set at P < 0.05 level. 
Conclusion 
From the previous results, it has been concluded that L-carnitine and coenzyme Q10 have 
a pronounced prophylactic effect against hepatotoxicity induced by halogenated alkanes 
such as carbon tetrachloride. Finally, it can be said that the combination of L-carnitine and 
CoQ10 is recommended for protecting the liver from CCl4 hazards. 
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